News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

SAGE Therapeutics Appoints Howard H. Pien To The Company’s Board Of Directors


4/1/2014 7:07:44 AM

free biotech news Get the latest biotech news where you want it. Sign up for the free 

GenePool newsletter today!

SAGE Therapeutics, a biopharmaceutical company developing novel medicines to treat life-threatening, rare central nervous system (CNS) disorders, today announced the appointment of Howard H. Pien to the company’s board of directors.

“Howard is a seasoned industry leader with deep biopharmaceutical expertise, especially in guiding companies as they expand and evolve from research and development to clinical stage,” said Jeff Jonas, M.D., chief executive officer of SAGE Therapeutics.

Help employers find you! Check out all the jobs and post your resume.

Read at BioSpace.com

comments powered by Disqus
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES